iBio (IBIO) Non-Current Debt (2020 - 2025)

iBio (IBIO) has 6 years of Non-Current Debt data on file, last reported at $64000.0 in Q2 2025.

• On a quarterly basis, Non-Current Debt fell 91.64% year-over-year to $64000.0 in Q2 2025; TTM through Jun 2025 was $64000.0, a 91.64% decrease from a year earlier, with the FY2025 full-year figure at $64000.0, down 91.64% from the prior year.
• Non-Current Debt for Q2 2025 stood at $64000.0, down from $643000.0 in the prior quarter.
• Over the last five years, Non-Current Debt for IBIO reached as high as $22.1 million in Q1 2022 and fell as low as $34000.0 in Q1 2021.
• Historically, Non-Current Debt has averaged $5.8 million across 5 years, with a median of $674500.0 in 2024.
• Across the five-year window, Non-Current Debt surged 64958.82% in 2022 and sank 91.64% in 2025, its largest moves.
• Year by year, Non-Current Debt stood at $22.1 million in 2021, then gained by 0.3% to $22.1 million in 2022, then plunged by 98.91% to $241000.0 in 2023, then soared by 166.8% to $643000.0 in 2024, then tumbled by 90.05% to $64000.0 in 2025.
• Per Business Quant data, the three most recent Non-Current Debt figures were $64000.0 in Q2 2025, $643000.0 in Q4 2024, and $706000.0 in Q3 2024.